サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1762458

遺伝子治療プラットフォーム市場、規模、シェア、動向分析レポート：プラットフォームタイプ別、用途別、送達モード別、最終用途別、地域別- 市場予測、2025年～2034年

Gene Therapy Platform Market Size, Share, & Trends Analysis Report: By Platform Type, By Application, By Delivery Mode (In Vivo, Ex Vivo, and Other), By End Use, and By Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 129 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
遺伝子治療プラットフォーム市場、規模、シェア、動向分析レポート：プラットフォームタイプ別、用途別、送達モード別、最終用途別、地域別- 市場予測、2025年～2034年
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 129 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、遺伝子治療プラットフォーム市場規模は2034年までに110億3,541万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

遺伝子治療プラットフォームは、病気の治療や予防のために欠陥遺伝子を修正または置換する遺伝子ベースの治療法を開発、提供、製造するために使用される包括的なシステムや技術です。遺伝子治療への投資は急増しており、政府、ベンチャーキャピタル、製薬会社から数百万米ドルが研究開発に投入されています。このような財政的支援により、バイオテクノロジー新興企業や研究機関は、より迅速に技術革新を行い、臨床試験を実施し、新しい治療法を市場に投入することができます。希少疾患や重篤な疾患を治療する遺伝子治療の高い可能性は、投資家にとって魅力的な分野となっています。企業間の合併・買収や共同研究は増加しており、より強力なプラットフォームやパイプラインの構築に役立っています。遺伝子治療技術を進歩させ、より多くの患者にその適用範囲を世界的に拡大するためには、このような強力な財政的後ろ盾が不可欠です。

遺伝子治療製品の臨床試験の成功例や規制当局の承認数が増加していることは、この治療法に対する信頼感を高めています。脊髄性筋萎縮症に対するゾルゲンスマや遺伝性視力低下に対するLuxturnaのような治療法は、有望で、しばしば人生を変える結果を示しています。肯定的な試験結果は、現実世界の安全性と有効性を実証し、研究と投資を後押しします。より多くの治療法が承認されれば、遺伝子治療の可能性が証明され、医師、患者、支払者に広く受け入れられることになります。このような成功は、新世代の治療への道を開き、遺伝子治療プラットフォーム市場に勢いを与え、そのすそ野を広げています。

遺伝子治療プラットフォーム市場レポートハイライト

2024年、ウイルスベクタープラットフォームセグメントは、細胞内への遺伝物質導入効率の高さから最大シェアを占める。

神経疾患分野は、パーキンソン病、脊髄性筋萎縮症（SMA）、ハンチントン病といった疾患の治療を一変させる大きな可能性を秘めた、遺伝子治療の主要な応用分野であるため、大きな成長が見込まれています。

2024年には、北米の遺伝子治療プラットフォーム市場が最大のシェアを占める。この地域は、先進的なヘルスケアインフラ、強力な政府支援、製薬・バイオテクノロジー企業による高い研究開発費の恩恵を受けているからです。

アジア太平洋地域の遺伝子治療プラットフォーム市場は、ヘルスケア投資の増加、バイオテクノロジー分野の拡大、規制枠組みの改善により大きな成長を遂げています。

世界の主要市場企業としては、Andelyn Biosciences社、AstraZeneca社、Autolomous Ltd社、BioIT社、DEEP GENOMICS社、ElevateBio社、IBM社、IDBS社、L7 Informatics社、Lonza社、Novartis社、Precision BioSciences社、Renova Therapeutics社、SAP SE社、Sarepta Therapeutics社、TrakCel社などが挙げられます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の遺伝子治療プラットフォーム市場の洞察

  • 市場スナップショット
  • 遺伝子治療プラットフォーム市場力学
    • 促進要因と機会
      • パーソナライズ医療の需要の高まり
      • 遺伝性疾患の増加
    • 抑制要因と課題
      • 初期投資額が高め
  • PESTEL分析
  • 遺伝子治療プラットフォーム市場の動向
  • バリューチェーン分析

第5章 世界の遺伝子治療プラットフォーム市場：プラットフォーム別

  • 主な調査結果
  • イントロダクション
  • ウイルスベクタープラットフォーム
  • 非ウイルスベクタープラットフォーム
  • 遺伝子編集プラットフォーム
  • CRISPR-Casシステム
  • TALENs
  • ZFN

第6章 世界の遺伝子治療プラットフォーム市場：用途別

  • 主な調査結果
  • イントロダクション
  • 腫瘍学
  • 希少遺伝性疾患
  • 心血管疾患
  • 神経疾患
  • 眼科疾患
  • 血液疾患
  • 筋骨格系障害
  • 感染症

第7章 世界の遺伝子治療プラットフォーム市場：送達モード別

  • 主な調査結果
  • イントロダクション
  • 生体内
  • 生体外
  • その他

第8章 世界の遺伝子治療プラットフォーム市場：最終用途別

  • 主な調査結果
  • イントロダクション
  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • 契約開発製造組織（CDMO）
  • 病院と遺伝子治療センター

第9章 世界の遺伝子治療プラットフォーム市場：地域別

  • 主な調査結果
  • イントロダクション
    • 遺伝子治療プラットフォーム市場評価：地域、2020年～2034年
  • 北米
    • 北米：プラットフォーム別、2020年～2034年
    • 北米：用途別、2020年～2034年
    • 北米：送達モード別、2020年～2034年
    • 北米：最終用途別、2020年～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：プラットフォーム別、2020年～2034年
    • 欧州：用途別、2020年～2034年
    • 欧州：送達モード別、2020年～2034年
    • 欧州：最終用途別、2020年～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他の欧州
  • アジア太平洋
    • アジア太平洋：プラットフォーム別、2020年～2034年
    • アジア太平洋：用途別、2020年～2034年
    • アジア太平洋：送達モード別、2020年～2034年
    • アジア太平洋：最終用途別、2020年～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他のアジア太平洋
  • 中東・アフリカ
    • 中東・アフリカ：プラットフォーム別、2020年～2034年
    • 中東・アフリカ：用途別、2020年～2034年
    • 中東・アフリカ：送達モード別、2020年～2034年
    • 中東・アフリカ：最終用途別、2020年～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ
  • ラテンアメリカ
    • ラテンアメリカ：プラットフォーム別、2020年～2034年
    • ラテンアメリカ：用途別、2020年～2034年
    • ラテンアメリカ：送達モード別、2020年～2034年
    • ラテンアメリカ：最終用途別、2020年～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他のラテンアメリカ

第10章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第11章 企業プロファイル

  • Andelyn Biosciences
  • AstraZeneca
  • Autolomous Ltd
  • BioIT
  • DEEP GENOMICS
  • ElevateBio
  • IBM
  • IDBS
  • L7 Informatics, Inc.
  • Lonza
  • Novartis
  • Precision BioSciences
  • Renova Therapeutics
  • SAP SE
  • Sarepta Therapeutics, Inc.
  • TrakCel
図表

List of Tables:

  • Table 1 Global Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 2 Global Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 3 Global Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 4 Global Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 5 North America: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 6 North America: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 7 North America: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 8 North America: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 9 US: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 10 US: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 11 US: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 12 US: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 13 Canada: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 14 Canada: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 15 Canada: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 16 Canada: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 17 Europe: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 18 Europe: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 19 Europe: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 20 Europe: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 21 UK: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 22 UK: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 23 UK: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 24 UK: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 25 France: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 26 France: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 27 France: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 28 France: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 29 Germany: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 30 Germany: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 31 Germany: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 32 Germany: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 33 Italy: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 34 Italy: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 35 Italy: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 36 Italy: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 37 Spain: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 38 Spain: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 39 Spain: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 40 Spain: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 41 Netherlands: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 42 Netherlands: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 43 Netherlands: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 44 Netherlands: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 45 Russia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 46 Russia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 47 Russia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 48 Russia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 49 Rest of Europe: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 50 Rest of Europe: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 51 Rest of Europe: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 52 Rest of Europe: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 53 Asia Pacific: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 54 Asia Pacific: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 55 Asia Pacific: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 56 Asia Pacific: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 57 China: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 58 China: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 59 China: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 60 China: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 61 India: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 62 India: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 63 India: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 64 India: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 65 Malaysia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 66 Malaysia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 67 Malaysia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 68 Malaysia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 69 Japan: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 70 Japan: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 71 Japan: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 72 Japan: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 73 Indonesia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 74 Indonesia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 75 Indonesia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 76 Indonesia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 77 South Korea: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 78 South Korea: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 79 South Korea: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 80 South Korea: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 81 Australia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 82 Australia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 83 Australia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 84 Australia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 85 Rest of Asia Pacific: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 86 Rest of Asia Pacific: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 87 Rest of Asia Pacific: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 88 Rest of Asia Pacific: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 89 Middle East & Africa: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 90 Middle East & Africa: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 91 Middle East & Africa: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 92 Middle East & Africa: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 93 Saudi Arabia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 94 Saudi Arabia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 95 Saudi Arabia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 96 Saudi Arabia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 97 UAE: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 98 UAE: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 99 UAE: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 100 UAE: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 101 Israel: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 102 Israel: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 103 Israel: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 104 Israel: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 105 South Africa: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 106 South Africa: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 107 South Africa: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 108 South Africa: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 109 Rest of Middle East & Africa: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 110 Rest of Middle East & Africa: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 111 Rest of Middle East & Africa: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 112 Rest of Middle East & Africa: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 113 Latin America: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 114 Latin America: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 115 Latin America: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 116 Latin America: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 117 Mexico: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 118 Mexico: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 119 Mexico: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 120 Mexico: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 121 Brazil: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 122 Brazil: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 123 Brazil: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 124 Brazil: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 125 Argentina: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 126 Argentina: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 127 Argentina: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 128 Argentina: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • Table 129 Rest of Latin America: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • Table 130 Rest of Latin America: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • Table 131 Rest of Latin America: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
  • Table 132 Rest of Latin America: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Gene Therapy Platform Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Platform
  • Figure 7. Global Gene Therapy Platform Market, by Platform, 2024 & 2034 (USD Million)
  • Figure 8. Market by Application
  • Figure 9. Global Gene Therapy Platform Market, by Application, 2024 & 2034 (USD Million)
  • Figure 10. Market by Delivery Mode
  • Figure 11. Global Gene Therapy Platform Market, by Delivery Mode, 2024 & 2034 (USD Million)
  • Figure 12. Market by End Use
  • Figure 13. Global Gene Therapy Platform Market, by End Use, 2024 & 2034 (USD Million)
  • Figure 14. Global Gene Therapy Platform Market Assessment, By Geography, 2020-2034 (USD Million)
  • Figure 15. Strategic Analysis - Global Gene Therapy Platform Market
目次
Product Code: PM5712

The gene therapy platform market size is expected to reach USD 11,035.41 million by 2034, according to a new study by Polaris Market Research. The report "Gene Therapy Platform Market Size, Share, & Trends Analysis Report: By Platform Type, By Application, By Delivery Mode (In Vivo, Ex Vivo, and Other), By End Use, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A gene therapy platform is a comprehensive system or technology used to develop, deliver, and manufacture gene-based treatments that modify or replace faulty genes to treat or prevent diseases. Investments in gene therapy have surged, with millions of dollars flowing from governments, venture capitalists, and pharmaceutical companies into research and development. This financial support enables biotech startups and research institutions to innovate faster, conduct clinical trials, and bring new therapies to market. The high potential of gene therapy to cure rare and serious diseases makes it an attractive area for investors. Mergers and acquisitions, and collaborations among companies are increasing, helping to build stronger platforms and pipelines. This strong financial backing is essential for advancing gene therapy technologies and expanding their reach to more patients globally.

The increasing number of successful clinical trials and regulatory approvals for gene therapy products boosts confidence in this treatment approach. Therapies such as Zolgensma for spinal muscular atrophy and Luxturna for inherited vision loss have shown promising, often life-changing results. Positive trial outcomes demonstrate real-world safety and effectiveness, encouraging research and investment. As more therapies receive approval, it validates the potential of gene therapy and drives broader acceptance by doctors, patients, and payers. These successes are paving the way for a new generation of treatments, creating momentum and expanding the scope of the gene therapy platform market.

Gene Therapy Platform Market Report Highlights

In 2024, the viral vector platforms segment dominated with the largest share due to their high efficiency in delivering genetic material into cells.

The neurological disorders segment is expected to experience significant growth as it is a major application area for gene therapy, with significant potential to transform treatment for diseases such as Parkinson's, spinal muscular atrophy (SMA), and Huntington's disease.

In 2024, the North America gene therapy platform market dominated with the largest share as the region benefits from advanced healthcare infrastructure, strong government support, and high R&D spending by pharmaceutical and biotech companies.

The Asia Pacific gene therapy platform market is experiencing significant growth due to rising healthcare investments, expanding biotech sectors, and improving regulatory frameworks.

A few global key market players are Andelyn Biosciences; AstraZeneca; Autolomous Ltd; BioIT; DEEP GENOMICS; ElevateBio; IBM; IDBS; L7 Informatics, Inc.; Lonza; Novartis; Precision BioSciences; Renova Therapeutics; SAP SE; Sarepta Therapeutics, Inc.; and TrakCel.

Polaris Market Research has segmented the gene therapy platform market report on the basis of platform type, application, delivery mode, end use, and region:

By Platform Type (Revenue - USD Million, 2020-2034)

Viral Vector Platforms

Adeno-Associated Virus (AAV)

Lentivirus

Retrovirus

Adenovirus

Herpes Simplex Virus (HSV)

Non-Viral Vector Platforms

Lipid Nanoparticles (LNPs)

Electroporation & Microinjection Platforms

Polymer-Based Delivery Systems

Naked DNA/RNA Delivery

Gene Editing Platforms

CRISPR-Cas Systems

TALENs

ZFNs

By Application (Revenue - USD Million, 2020-2034)

Oncology

Rare Genetic Disorders

Cardiovascular Diseases

Neurological Disorders

Ophthalmic Diseases

Hematological Disorders

Musculoskeletal Disorders

Infectious Diseases

By Delivery Mode (Revenue - USD Million, 2020-2034)

In Vivo

Ex Vivo

Other

By End Use (Revenue - USD Million, 2020-2034)

Pharmaceutical & Biotechnology Companies

Academic & Research Institutions

Contract Development & Manufacturing Organizations (CDMOs)

Hospitals & Gene Therapy Centers

By Regional Outlook (Revenue - USD Million, 2020-2034)

North America

US

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Gene Therapy Platform Market Insights

  • 4.1. Gene Therapy Platform Market - Market Snapshot
  • 4.2. Gene Therapy Platform Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Demand for Personalized Medicine
      • 4.2.1.2. Growing Prevalence of Genetic Disorder
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Investment
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gene Therapy Platform Market Trends
  • 4.6. Value Chain Analysis

5. Global Gene Therapy Platform Market, by Platform

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
  • 5.3. Viral Vector Platforms
    • 5.3.1. Global Gene Therapy Platform Market, by Viral Vector Platforms, by Region, 2020-2034 (USD Million)
    • 5.3.2. Adeno-associated Virus (AAV)
      • 5.3.2.1. Global Gene Therapy Platform Market, by Adeno-associated Virus (AAV), by Region, 2020-2034 (USD Million)
    • 5.3.3. Lentivirus
      • 5.3.3.1. Global Gene Therapy Platform Market, by Lentivirus, by Region, 2020-2034 (USD Million)
    • 5.3.4. Retrovirus
      • 5.3.4.1. Global Gene Therapy Platform Market, by Retrovirus, by Region, 2020-2034 (USD Million)
    • 5.3.5. Adenovirus
      • 5.3.5.1. Global Gene Therapy Platform Market, by Adenovirus, by Region, 2020-2034 (USD Million)
    • 5.3.6. Herpes Simplex Virus (HSV)
      • 5.3.6.1. Global Gene Therapy Platform Market, by Herpes Simplex Virus (HSV), by Region, 2020-2034 (USD Million)
  • 5.4. Non-Viral Vector Platforms
    • 5.4.1. Global Gene Therapy Platform Market, by Non-Viral Vector Platforms, by Region, 2020-2034 (USD Million)
    • 5.4.2. Lipid Nanoparticles (LNPs)
      • 5.4.2.1. Global Gene Therapy Platform Market, by Lipid Nanoparticles (LNPs), by Region, 2020-2034 (USD Million)
    • 5.4.3. Electroporation & Microinjection Platforms
      • 5.4.3.1. Global Gene Therapy Platform Market, by Electroporation & Microinjection Platforms by Region, 2020-2034 (USD Million)
    • 5.4.4. Polymer-based Delivery Systems
      • 5.4.4.1. Global Gene Therapy Platform Market, by Polymer-based Delivery Systems by Region, 2020-2034 (USD Million)
    • 5.4.5. Naked DNA/RNA Delivery
      • 5.4.5.1. Global Gene Therapy Platform Market, by Naked DNA/RNA Delivery by Region, 2020-2034 (USD Million)
  • 5.5. Gene Editing Platforms
    • 5.5.1. Global Gene Therapy Platform Market, by Gene Editing Platforms by Region, 2020-2034 (USD Million)
  • 5.6. CRISPR-Cas Systems
    • 5.6.1. Global Gene Therapy Platform Market, by CRISPR-Cas Systems by Region, 2020-2034 (USD Million)
  • 5.7. TALENs
    • 5.7.1. Global Gene Therapy Platform Market, by TALENs by Region, 2020-2034 (USD Million)
  • 5.8. ZFNs
    • 5.8.1. Global Gene Therapy Platform Market, by ZFNs by Region, 2020-2034 (USD Million)
    • 5.8.2.

6. Global Gene Therapy Platform Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
  • 6.3. Oncology
    • 6.3.1. Global Gene Therapy Platform Market, by Oncology, by Region, 2020-2034 (USD Million)
  • 6.4. Rare Genetic Disorders
    • 6.4.1. Global Gene Therapy Platform Market, by Rare Genetic Disorders, by Region, 2020-2034 (USD Million)
  • 6.5. Cardiovascular Diseases
    • 6.5.1. Global Gene Therapy Platform Market, by Cardiovascular Diseases, by Region, 2020-2034 (USD Million)
  • 6.6. Neurological Disorders
    • 6.6.1. Global Gene Therapy Platform Market, by Neurological Disorders, by Region, 2020-2034 (USD Million)
  • 6.7. Ophthalmic Diseases
    • 6.7.1. Global Gene Therapy Platform Market, by Ophthalmic Diseases, by Region, 2020-2034 (USD Million)
  • 6.8. Hematological Disorders
    • 6.8.1. Global Gene Therapy Platform Market, by Hematological Disorders, by Region, 2020-2034 (USD Million)
  • 6.9. Musculoskeletal Disorders
    • 6.9.1. Global Gene Therapy Platform Market, by Musculoskeletal Disorders, by Region, 2020-2034 (USD Million)
  • 6.10. Infectious Diseases
    • 6.10.1. Global Gene Therapy Platform Market, by Infectious Diseases, by Region, 2020-2034 (USD Million)

7. Global Gene Therapy Platform Market, by Delivery Mode

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gene Therapy Platform Market, by Medical Biotechnology, 2020-2034 (USD Million)
  • 7.3. In Vivo
    • 7.3.1. Global Gene Therapy Platform Market, by In Vivo, by Region, 2020-2034 (USD Million)
  • 7.4. Ex Vivo
    • 7.4.1. Global Gene Therapy Platform Market, by Ex Vivo, by Region, 2020-2034 (USD Million)
  • 7.5. Other
    • 7.5.1. Global Gene Therapy Platform Market, by Other, by Region, 2020-2034 (USD Million)

8. Global Gene Therapy Platform Market, by End Use

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • 8.3. Pharmaceutical & Biotechnology Companies
    • 8.3.1. Global Gene Therapy Platform Market, by Pharmaceutical & Biotechnology Companies, by Region, 2020-2034 (USD Million)
  • 8.4. Academic & Research Institutions
    • 8.4.1. Global Gene Therapy Platform Market, by Academic & Research Institutions, by Region, 2020-2034 (USD Million)
  • 8.5. Contract Development & Manufacturing Organizations (CDMOs)
    • 8.5.1. Global Gene Therapy Platform Market, by Contract Development & Manufacturing Organizations (CDMOs), 2020-2034 (USD Million)
  • 8.6. Hospitals & Gene Therapy Centers
    • 8.6.1. Global Gene Therapy Platform Market, by Hospitals & Gene Therapy Centers, by Region, 2020-2034 (USD Million)

9. Global Gene Therapy Platform Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Gene Therapy Platform Market Assessment, By Geography, 2020-2034 (USD Million)
  • 9.3. Gene Therapy Platform Market - North America
    • 9.3.1. North America: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
    • 9.3.2. North America: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
    • 9.3.3. North America: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
    • 9.3.4. North America: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.3.5. Gene Therapy Platform Market - US
      • 9.3.5.1. US: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.3.5.2. US: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.3.5.3. US: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.3.5.4. US: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.3.6. Gene Therapy Platform Market - Canada
      • 9.3.6.1. Canada: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.3.6.2. Canada: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.3.6.3. Canada: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.3.6.4. Canada: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • 9.4. Gene Therapy Platform Market - Europe
    • 9.4.1. Europe: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
    • 9.4.2. Europe: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
    • 9.4.3. Europe: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
    • 9.4.4. Europe: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.5. Gene Therapy Platform Market - UK
      • 9.4.5.1. UK: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.5.2. UK: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.5.3. UK: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.5.4. UK: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.6. Gene Therapy Platform Market - France
      • 9.4.6.1. France: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.6.2. France: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.6.3. France: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.6.4. France: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.7. Gene Therapy Platform Market - Germany
      • 9.4.7.1. Germany: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.7.2. Germany: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.7.3. Germany: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.7.4. Germany: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.8. Gene Therapy Platform Market - Italy
      • 9.4.8.1. Italy: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.8.2. Italy: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.8.3. Italy: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.8.4. Italy: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.9. Gene Therapy Platform Market - Spain
      • 9.4.9.1. Spain: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.9.2. Spain: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.9.3. Spain: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.9.4. Spain: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.10. Gene Therapy Platform Market - Netherlands
      • 9.4.10.1. Netherlands: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.10.2. Netherlands: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.10.3. Netherlands: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.10.4. Netherlands: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.11. Gene Therapy Platform Market - Russia
      • 9.4.11.1. Russia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.11.2. Russia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.11.3. Russia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.11.4. Russia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.4.12. Gene Therapy Platform Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.4.12.2. Rest of Europe: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.4.12.3. Rest of Europe: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.4.12.4. Rest of Europe: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • 9.5. Gene Therapy Platform Market - Asia Pacific
    • 9.5.1. Asia Pacific: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
    • 9.5.2. Asia Pacific: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
    • 9.5.3. Asia Pacific: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
    • 9.5.4. Asia Pacific: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.5. Gene Therapy Platform Market - China
      • 9.5.5.1. China: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.5.2. China: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.5.3. China: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.5.4. China: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.6. Gene Therapy Platform Market - India
      • 9.5.6.1. India: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.6.2. India: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.6.3. India: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.6.4. India: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.7. Gene Therapy Platform Market - Malaysia
      • 9.5.7.1. Malaysia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.7.2. Malaysia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.7.3. Malaysia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.7.4. Malaysia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.8. Gene Therapy Platform Market - Japan
      • 9.5.8.1. Japan: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.8.2. Japan: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.8.3. Japan: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.8.4. Japan: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.9. Gene Therapy Platform Market - Indonesia
      • 9.5.9.1. Indonesia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.9.2. Indonesia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.9.3. Indonesia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.9.4. Indonesia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.10. Gene Therapy Platform Market - South Korea
      • 9.5.10.1. South Korea: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.10.2. South Korea: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.10.3. South Korea: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.10.4. South Korea: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.11. Gene Therapy Platform Market - Australia
      • 9.5.11.1. Australia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.11.2. Australia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.11.3. Australia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.11.4. Australia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.5.12. Gene Therapy Platform Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.5.12.2. Rest of Asia Pacific: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.5.12.3. Rest of Asia Pacific: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.5.12.4. Rest of Asia Pacific: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • 9.6. Gene Therapy Platform Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
    • 9.6.2. Middle East & Africa: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
    • 9.6.3. Middle East & Africa: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
    • 9.6.4. Middle East & Africa: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.6.5. Gene Therapy Platform Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.6.5.2. Saudi Arabia: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.6.5.3. Saudi Arabia: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.6.5.4. Saudi Arabia: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.6.6. Gene Therapy Platform Market - UAE
      • 9.6.6.1. UAE: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.6.6.2. UAE: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.6.6.3. UAE: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.6.6.4. UAE: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.6.7. Gene Therapy Platform Market - Israel
      • 9.6.7.1. Israel: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.6.7.2. Israel: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.6.7.3. Israel: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.6.7.4. Israel: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.6.8. Gene Therapy Platform Market - South Africa
      • 9.6.8.1. South Africa: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.6.8.2. South Africa: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.6.8.3. South Africa: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.6.8.4. South Africa: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.6.9. Gene Therapy Platform Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.6.9.2. Rest of Middle East & Africa: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.6.9.3. Rest of Middle East & Africa: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.6.9.4. Rest of Middle East & Africa: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
  • 9.7. Gene Therapy Platform Market - Latin America
    • 9.7.1. Latin America: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
    • 9.7.2. Latin America: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
    • 9.7.3. Latin America: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
    • 9.7.4. Latin America: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.7.5. Gene Therapy Platform Market - Mexico
      • 9.7.5.1. Mexico: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.7.5.2. Mexico: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.7.5.3. Mexico: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.7.5.4. Mexico: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.7.6. Gene Therapy Platform Market - Brazil
      • 9.7.6.1. Brazil: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.7.6.2. Brazil: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.7.6.3. Brazil: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.7.6.4. Brazil: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.7.7. Gene Therapy Platform Market - Argentina
      • 9.7.7.1. Argentina: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.7.7.2. Argentina: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.7.7.3. Argentina: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.7.7.4. Argentina: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)
    • 9.7.8. Gene Therapy Platform Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Gene Therapy Platform Market, by Platform, 2020-2034 (USD Million)
      • 9.7.8.2. Rest of Latin America: Gene Therapy Platform Market, by Application, 2020-2034 (USD Million)
      • 9.7.8.3. Rest of Latin America: Gene Therapy Platform Market, by Delivery Mode, 2020-2034 (USD Million)
      • 9.7.8.4. Rest of Latin America: Gene Therapy Platform Market, by End Use, 2020-2034 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Andelyn Biosciences
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. AstraZeneca
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Autolomous Ltd
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. BioIT
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. DEEP GENOMICS
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. ElevateBio
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. IBM
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. IDBS
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. L7 Informatics, Inc.
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Lonza
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Novartis
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Precision BioSciences
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Renova Therapeutics
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. SAP SE
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Sarepta Therapeutics, Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. TrakCel
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development